Advertisement

Topics

BMS' Opdivo Approval In CRC Overshadowed By Keytruda Dominance

09:26 EDT 2 Aug 2017 | SCRIP

The US FDA has approved BMS' Opdivo for previously treated patients with some forms of colorectal cancer, however direct competition...

      

Related Stories

 

Original Article: BMS' Opdivo Approval In CRC Overshadowed By Keytruda Dominance

NEXT ARTICLE

More From BioPortfolio on "BMS' Opdivo Approval In CRC Overshadowed By Keytruda Dominance"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...